| - GRCh37:
- Chr2:230678973-230678986
- GRCh38:
- Chr2:229814257-229814270
| TRIP12 | M251fs, M548fs, M554fs, M567fs, M596fs | Clark-Baraitser syndrome | Pathogenic (Oct 30, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr2:230650537
- GRCh38:
- Chr2:229785821
| TRIP12 | A1332V, A1630V, A1643V, A1651V, A1678V, A1602V, A1603V, A1672V, A1673V, A1635V, A1650V, A1677V | Clark-Baraitser syndrome | Likely pathogenic (Oct 25, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230656680
- GRCh38:
- Chr2:229791964
| TRIP12 | Q1095fs, Q1365fs, Q1366fs, Q1393fs, Q1398fs, Q1406fs, Q1413fs, Q1414fs, Q1435fs, Q1436fs, Q1440fs, Q1441fs | Clark-Baraitser syndrome | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:230632346-230632348
- GRCh38:
- Chr2:229767630-229767632
| TRIP12 | Y1698fs, Y1968fs, Y1969fs, Y1996fs, Y2001fs, Y2009fs, Y2016fs, Y2017fs, Y2038fs, Y2039fs, Y2043fs, Y2044fs | Clark-Baraitser syndrome | Uncertain significance (Mar 7, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230723503
- GRCh38:
- Chr2:229858787
| TRIP12 | Q296*, Q309*, Q338* | Clark-Baraitser syndrome | Pathogenic (Jul 18, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230659994
- GRCh38:
- Chr2:229795278
| TRIP12 | L1215fs, L1221fs, L1248fs, L1261fs, L1263fs, L1264fs, L1290fs, L1291fs, L945fs | Clark-Baraitser syndrome | Likely pathogenic (Aug 7, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230668826-230668827
- GRCh38:
- Chr2:229804110-229804111
| TRIP12 | S578*, S848*, S854*, S881*, S894*, S896*, S897*, S923*, S924* | Clark-Baraitser syndrome | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:230683169
- GRCh38:
- Chr2:229818453
| TRIP12 | Q159*, Q456*, Q462*, Q475*, Q504* | Clark-Baraitser syndrome | not provided | no assertion provided |
| - GRCh37:
- Chr2:230668909-230668915
- GRCh38:
- Chr2:229804193-229804199
| TRIP12 | D548fs, D818fs, D824fs, D851fs, D864fs, D866fs, D867fs, D893fs, D894fs | Clark-Baraitser syndrome | Likely pathogenic (Apr 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr2:230675752
- GRCh38:
- Chr2:229811036
| TRIP12 | Q344*, Q641*, Q647*, Q660*, Q689* | Clark-Baraitser syndrome | Pathogenic (Feb 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230670467-230670471
- GRCh38:
- Chr2:229805751-229805755
| TRIP12 | N531fs, N801fs, N807fs, N834fs, N847fs, N849fs, N850fs, N876fs, N877fs | Clark-Baraitser syndrome | Likely pathogenic (Jan 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230638832
- GRCh38:
- Chr2:229774116
| TRIP12 | N1547fs, N1817fs, N1818fs, N1845fs, N1850fs, N1858fs, N1865fs, N1866fs, N1887fs, N1888fs, N1892fs, N1893fs | Clark-Baraitser syndrome | Pathogenic (Dec 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230656720
- GRCh38:
- Chr2:229792004
| TRIP12 | H1081R, H1351R, H1352R, H1379R, H1384R, H1392R, H1399R, H1400R, H1421R, H1422R, H1426R, H1427R | Clark-Baraitser syndrome | Uncertain significance (Nov 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230663674
- GRCh38:
- Chr2:229798958
| TRIP12 | N1058K, N1064K, N1091K, N1104K, N1106K, N1107K, N1133K, N1134K, N788K | Clark-Baraitser syndrome | Uncertain significance (Oct 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230664106
- GRCh38:
- Chr2:229799390
| TRIP12 | | Clark-Baraitser syndrome | Uncertain significance (Apr 29, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230724186
- GRCh38:
- Chr2:229859470
| TRIP12 | N110S, N68S | Clark-Baraitser syndrome | Uncertain significance (Dec 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230701657
- GRCh38:
- Chr2:229836941
| TRIP12 | R351C, R364C, R393C, R48C | Clark-Baraitser syndrome | Uncertain significance (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230678650
- GRCh38:
- Chr2:229813934
| TRIP12 | T296M, T593M, T599M, T612M, T641M | Clark-Baraitser syndrome, not provided | Conflicting interpretations of pathogenicity (May 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:230654412
- GRCh38:
- Chr2:229789696
| TRIP12 | I1192T, I1462T, I1463T, I1490T, I1495T, I1503T, I1510T, I1511T, I1532T, I1533T, I1537T, I1538T | Clark-Baraitser syndrome | Uncertain significance (Nov 20, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230675898
- GRCh38:
- Chr2:229811182
| TRIP12 | T325I, T622I, T628I, T641I, T670I | Clark-Baraitser syndrome | Uncertain significance (Mar 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230661341
- GRCh38:
- Chr2:229796625
| TRIP12 | L1186S, L1192S, L1219S, L1232S, L1234S, L1235S, L1261S, L1262S, L916S | Clark-Baraitser syndrome | Uncertain significance (Oct 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230672524
- GRCh38:
- Chr2:229807808
| TRIP12 | K454R, K751R, K757R, K770R, K799R | Clark-Baraitser syndrome | Uncertain significance (Sep 25, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230654375-230654377
- GRCh38:
- Chr2:229789659-229789661
| TRIP12 | L1205del, L1475del, L1476del, L1503del, L1508del, L1516del, L1523del, L1524del, L1545del, L1546del, L1550del, L1551del | Clark-Baraitser syndrome | Likely pathogenic (Dec 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230678950
- GRCh38:
- Chr2:229814234
| TRIP12 | A579V, A608V, A566V, A263V, A560V | Clark-Baraitser syndrome, Inborn genetic diseases | Conflicting interpretations of pathogenicity (Nov 15, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:230673034
- GRCh38:
- Chr2:229808318
| TRIP12 | C710Y, C716Y, C758Y, C413Y, C729Y | Inborn genetic diseases, Clark-Baraitser syndrome | Uncertain significance (Jan 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:230723551
- GRCh38:
- Chr2:229858835
| TRIP12 | P322T, P280T | Clark-Baraitser syndrome, Inborn genetic diseases | Uncertain significance (Dec 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:230642107-230642108
- GRCh38:
- Chr2:229777391-229777392
| TRIP12 | P1744fs, P1791fs, P1813fs, P1473fs, P1743fs, P1771fs, P1776fs, P1784fs, P1818fs, P1819fs, P1792fs, P1814fs | Clark-Baraitser syndrome | Pathogenic (Dec 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230653563
- GRCh38:
- Chr2:229788847
| TRIP12 | I1252V, I1522V, I1523V, I1550V, I1555V, I1563V, I1570V, I1571V, I1592V, I1593V, I1597V, I1598V | Clark-Baraitser syndrome | Uncertain significance (May 25, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230723580
- GRCh38:
- Chr2:229858864
| TRIP12 | V270G, V312G | Clark-Baraitser syndrome | Uncertain significance (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230705581
- GRCh38:
- Chr2:229840865
| TRIP12 | R322W, R335W, R364W | Clark-Baraitser syndrome | Uncertain significance (Dec 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:230632364-230632365
- GRCh38:
- Chr2:229767648-229767649
| TRIP12 | Y1692*, Y1962*, Y1963*, Y1990*, Y1995*, Y2003*, Y2010*, Y2011*, Y2032*, Y2033*, Y2037*, Y2038* | Clark-Baraitser syndrome | Likely pathogenic (Nov 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230656783
- GRCh38:
- Chr2:229792067
| TRIP12 | | Clark-Baraitser syndrome | Pathogenic (Jun 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230654413
- GRCh38:
- Chr2:229789697
| TRIP12 | I1192V, I1462V, I1463V, I1490V, I1495V, I1503V, I1510V, I1511V, I1532V, I1533V, I1537V, I1538V | Clark-Baraitser syndrome | Likely benign (Sep 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230723823
- GRCh38:
- Chr2:229859107
| TRIP12 | G189A, G231A | Clark-Baraitser syndrome | Uncertain significance (Mar 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230661305
- GRCh38:
- Chr2:229796589
| TRIP12 | | Clark-Baraitser syndrome | Pathogenic (May 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230652352
- GRCh38:
- Chr2:229787636
| TRIP12 | R1277W, R1547W, R1548W, R1575W, R1580W, R1588W, R1595W, R1596W, R1617W, R1618W, R1622W, R1623W | not provided, Clark-Baraitser syndrome | Conflicting interpretations of pathogenicity (Jul 27, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:230744718
- GRCh38:
- Chr2:229880002
| TRIP12 | Q26H | Clark-Baraitser syndrome | Uncertain significance (May 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230666560
- GRCh38:
- Chr2:229801844
| TRIP12 | | Clark-Baraitser syndrome | Uncertain significance (Jul 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230723767
- GRCh38:
- Chr2:229859051
| TRIP12 | A208T, A250T | Clark-Baraitser syndrome, Inborn genetic diseases, not provided
| Conflicting interpretations of pathogenicity (May 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:230724027
- GRCh38:
- Chr2:229859311
| TRIP12 | Q121L, Q163L | Clark-Baraitser syndrome | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr2:230643237-230643254
- GRCh38:
- Chr2:229778521-229778538
| TRIP12 | L1409fs, L1679fs, L1680fs, L1707fs, L1712fs, L1720fs, L1727fs, L1728fs, L1749fs, L1750fs, L1754fs, L1755fs | Clark-Baraitser syndrome | Likely pathogenic (Sep 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230661398
- GRCh38:
- Chr2:229796682
| TRIP12 | L1167P, L1173P, L1200P, L1213P, L1215P, L1216P, L1242P, L1243P, L897P | Clark-Baraitser syndrome | Uncertain significance (Apr 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230663639
- GRCh38:
- Chr2:229798923
| TRIP12 | G1070V, G1076V, G1103V, G1116V, G1118V, G1119V, G1145V, G1146V, G800V | Clark-Baraitser syndrome | Uncertain significance (Aug 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230668818
- GRCh38:
- Chr2:229804102
| TRIP12 | G581*, G851*, G857*, G884*, G897*, G899*, G900*, G926*, G927* | Clark-Baraitser syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:230633401
- GRCh38:
- Chr2:229768685
| TRIP12 | S1635G, S1905G, S1906G, S1933G, S1938G, S1946G, S1953G, S1954G, S1975G, S1976G, S1980G, S1981G | Clark-Baraitser syndrome | Uncertain significance (May 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230725209
- GRCh38:
- Chr2:229860493
| TRIP12 | P46L | Clark-Baraitser syndrome | Uncertain significance (Apr 24, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230701674
- GRCh38:
- Chr2:229836958
| TRIP12 | R345K, R358K, R387K, R42K | Clark-Baraitser syndrome | Uncertain significance (Oct 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230668858
- GRCh38:
- Chr2:229804142
| TRIP12 | | not provided, Clark-Baraitser syndrome | Benign (Sep 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:230668968
- GRCh38:
- Chr2:229804252
| TRIP12 | | not provided, Clark-Baraitser syndrome | Benign (Sep 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:230653626
- GRCh38:
- Chr2:229788910
| TRIP12 | S1231fs, S1501fs, S1502fs, S1529fs, S1534fs, S1542fs, S1549fs, S1550fs, S1571fs, S1572fs, S1576fs, S1577fs | Clark-Baraitser syndrome | Pathogenic (Feb 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230668982
- GRCh38:
- Chr2:229804266
| TRIP12 | | not provided, Clark-Baraitser syndrome | Benign (Sep 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:230705517
- GRCh38:
- Chr2:229840801
| TRIP12 | | Clark-Baraitser syndrome, not provided | Benign (Sep 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:230663576
- GRCh38:
- Chr2:229798860
| TRIP12 | | not provided, Clark-Baraitser syndrome | Benign (Sep 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:230672541-230672542
- GRCh38:
- Chr2:229807825-229807826
| TRIP12 | V449fs, V746fs, V752fs, V765fs, V794fs | Clark-Baraitser syndrome | Pathogenic (May 13, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:230652312
- GRCh38:
- Chr2:229787596
| TRIP12 | R1290Q, R1560Q, R1561Q, R1588Q, R1593Q, R1601Q, R1608Q, R1609Q, R1630Q, R1631Q, R1635Q, R1636Q | Clark-Baraitser syndrome | Likely pathogenic (May 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230652288
- GRCh38:
- Chr2:229787572
| TRIP12 | T1298N, T1568N, T1569N, T1596N, T1601N, T1609N, T1616N, T1617N, T1638N, T1639N, T1643N, T1644N | Clark-Baraitser syndrome | Uncertain significance (Jan 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230642131
- GRCh38:
- Chr2:229777415
| TRIP12 | S1763L, S1768L, S1465L, S1736L, S1805L, S1811L, S1735L, S1783L, S1806L, S1810L, S1776L, S1784L | Clark-Baraitser syndrome | Uncertain significance (Mar 22, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230656744
- GRCh38:
- Chr2:229792028
| TRIP12 | R1073K, R1344K, R1413K, R1419K, R1391K, R1392K, R1418K, R1343K, R1376K, R1371K, R1384K, R1414K | Clark-Baraitser syndrome | Uncertain significance (Mar 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:230660028
- GRCh38:
- Chr2:229795312
| TRIP12 | I1204V, I1210V, I934V, I1280V, I1237V, I1250V, I1252V, I1253V, I1279V | Clark-Baraitser syndrome | Uncertain significance (Mar 23, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230723526
- GRCh38:
- Chr2:229858810
| TRIP12 | S288L, S301L, S330L | Clark-Baraitser syndrome | Uncertain significance (Jan 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230723812
- GRCh38:
- Chr2:229859096
| TRIP12 | I193V, I235V | Clark-Baraitser syndrome | Uncertain significance (Jun 6, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230642100-230642101
- GRCh38:
- Chr2:229777384-229777385
| TRIP12 | A1476fs, A1816fs, A1774fs, A1795fs, A1746fs, A1747fs, A1787fs, A1794fs, A1779fs, A1817fs, A1821fs, A1822fs | Clark-Baraitser syndrome | Pathogenic (Apr 23, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230643205
- GRCh38:
- Chr2:229778489
| TRIP12 | M1728V, M1765V, M1766V, M1770V, M1695V, M1723V, M1736V, M1744V, M1425V, M1696V, M1743V, M1771V | Clark-Baraitser syndrome | Uncertain significance (Jul 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230653512
- GRCh38:
- Chr2:229788796
| TRIP12 | | Clark-Baraitser syndrome | Likely pathogenic (Jan 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230724115-230724116
- GRCh38:
- Chr2:229859399-229859400
| TRIP12 | P134fs, P92fs | Clark-Baraitser syndrome | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:230675746
- GRCh38:
- Chr2:229811030
| TRIP12 | V346F, V643F, V649F, V662F, V691F | Clark-Baraitser syndrome | Uncertain significance (Apr 20, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230662539-230662540
- GRCh38:
- Chr2:229797823-229797824
| TRIP12 | I1089fs, I1095fs, I1122fs, I1135fs, I1137fs, I1138fs, I1164fs, I1165fs, I819fs | Inborn genetic diseases, See cases, Clark-Baraitser syndrome, not provided | Pathogenic (Jul 25, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:230632352
- GRCh38:
- Chr2:229767636
| TRIP12 | P1696L, P1966L, P1967L, P1994L, P1999L, P2007L, P2014L, P2015L, P2036L, P2037L, P2041L, P2042L | Clark-Baraitser syndrome | Likely pathogenic (Apr 3, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:230632290
- GRCh38:
- Chr2:229767574
| TRIP12 | Q1717*, Q1987*, Q1988*, Q2015*, Q2020*, Q2028*, Q2035*, Q2036*, Q2057*, Q2058*, Q2062*, Q2063* | Clark-Baraitser syndrome | Uncertain significance (May 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230661349
- GRCh38:
- Chr2:229796633
| TRIP12 | E1183D, E1189D, E1216D, E1229D, E1231D, E1232D, E1258D, E1259D, E913D | Clark-Baraitser syndrome | Uncertain significance (May 14, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230705634
- GRCh38:
- Chr2:229840918
| TRIP12 | K304R, K317R, K346R | Clark-Baraitser syndrome | Uncertain significance (Mar 5, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230656628-230656629
- GRCh38:
- Chr2:229791912-229791913
| TRIP12 | N1410fs, N1423fs, N1382fs, N1415fs, N1430fs, N1452fs, N1453fs, N1457fs, N1112fs, N1383fs, N1431fs, N1458fs | Clark-Baraitser syndrome | Pathogenic (Jan 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230693978
- GRCh38:
- Chr2:229829262
| TRIP12 | P461T, P116T, P413T, P419T, P432T | Clark-Baraitser syndrome | Uncertain significance (Jan 27, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230675869
- GRCh38:
- Chr2:229811153
| TRIP12 | N632D, N680D, N335D, N651D, N638D | Clark-Baraitser syndrome | Uncertain significance (Jan 8, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230661315
- GRCh38:
- Chr2:229796599
| TRIP12 | S1195fs, S1201fs, S1244fs, S1271fs, S1241fs, S1243fs, S1270fs, S1228fs, S925fs | Clark-Baraitser syndrome | Likely pathogenic (Oct 23, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230664098
- GRCh38:
- Chr2:229799382
| TRIP12 | R1028*, R1001*, R1044*, R1070*, R1071*, R725*, R995*, R1041*, R1043* | not provided | Likely pathogenic (Mar 21, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230679862
- GRCh38:
- Chr2:229815146
| TRIP12 | R217*, R520*, R562*, R514*, R533* | Clark-Baraitser syndrome | Pathogenic (Jan 9, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230723532
- GRCh38:
- Chr2:229858816
| TRIP12 | E299A, E328A, E286A | Clark-Baraitser syndrome, not provided | Uncertain significance (Mar 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:230667008
- GRCh38:
- Chr2:229802292
| TRIP12 | Q1057*, Q987*, Q1014*, Q1027*, Q981*, Q1056*, Q1029*, Q1030*, Q711* | Clark-Baraitser syndrome | Pathogenic (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230652230
- GRCh38:
- Chr2:229787514
| TRIP12 | D1635E, D1657E, D1662E, D1663E, D1588E, D1615E, D1628E, D1658E, D1587E, D1317E, D1620E, D1636E | Clark-Baraitser syndrome | Likely pathogenic (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230632440
- GRCh38:
- Chr2:229767724
| TRIP12 | T1985A, T2007A, T2008A, T2012A, T1937A, T1978A, T1986A, T1938A, T1667A, T1965A, T1970A, T2013A | Clark-Baraitser syndrome | Uncertain significance (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230636242
- GRCh38:
- Chr2:229771526
| TRIP12 | P1892L, P1907L, P1935L, P1860L, P1900L, P1908L, P1930L, P1589L, P1859L, P1887L, P1929L, P1934L | Clark-Baraitser syndrome | Conflicting interpretations of pathogenicity (Jun 24, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:230656679
- GRCh38:
- Chr2:229791963
| TRIP12 | Q1413*, Q1393*, Q1414*, Q1436*, Q1441*, Q1435*, Q1095*, Q1365*, Q1366*, Q1440*, Q1398*, Q1406* | Clark-Baraitser syndrome | Pathogenic (May 15, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230679895
- GRCh38:
- Chr2:229815179
| TRIP12 | R503*, R551*, R206*, R509*, R522* | not provided, Clark-Baraitser syndrome | Pathogenic (Jan 1, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:230659894
- GRCh38:
- Chr2:229795178
| TRIP12 | | Clark-Baraitser syndrome | Pathogenic (Apr 15, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:230666969-230666970
- GRCh38:
- Chr2:229802253-229802254
| TRIP12 | G1000fs, G1042fs, G724fs, G1070fs, G1040fs, G1069fs, G1027fs, G1043fs, G994fs | Clark-Baraitser syndrome | Pathogenic (Apr 15, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:230661451-230661452
- GRCh38:
- Chr2:229796735-229796736
| TRIP12 | | not provided | Pathogenic (Jun 15, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:230650558
- GRCh38:
- Chr2:229785842
| TRIP12 | R1628Q, R1643Q, R1325Q, R1596Q, R1665Q, R1595Q, R1623Q, R1636Q, R1666Q, R1644Q, R1670Q, R1671Q | Clark-Baraitser syndrome | Pathogenic (Apr 15, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:230663590
- GRCh38:
- Chr2:229798874
| TRIP12 | | Clark-Baraitser syndrome | Pathogenic (Apr 15, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:230723928-230723929
- GRCh38:
- Chr2:229859212-229859213
| TRIP12 | S154fs, S196fs | Clark-Baraitser syndrome | Pathogenic (Apr 15, 2020) | no assertion criteria provided |